Determine the necessary mass, volume, or concentration for preparing a solution.
This is a demo store. No orders will be fulfilled.
| SKU | Size | Availability |
Price | Qty |
|---|---|---|---|---|
|
S413970-10mg
|
10mg |
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
|
$68.90
|
|
|
S413970-50mg
|
50mg |
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
|
$286.90
|
|
|
S413970-250mg
|
250mg |
2
|
$1,291.90
|
|
Wnt/beta-catenin Agonists
| Synonyms | 3-Isoxazolecarboxamide,5-(2-furanyl)-N-[3-(1H-imidazol-1-yl)propyl]- |
|---|---|
| Specifications & Purity | ≥99% |
| Biochemical and Physiological Mechanisms | SKL2001 is a novel agonist of the Wnt/β-catenin pathway. It disrupts the Axin/β-catenin interaction. |
| Storage Temp | Store at -20°C |
| Shipped In |
Ice chest + Ice pads This product requires cold chain shipping. Ground and other economy services are not available. |
| Product Description |
Information SKL2001 SKL2001 is a novel agonist of the Wnt/β-catenin pathway . It disrupts the Axin/β-catenin interaction. Targets Wnt/β-catenin (Cell-free assay) In vitro SKL2001 upregulated β-catenin responsive transcription by increasing the intracellular β-catenin protein level and inhibited the phosphorylation of β-catenin at residues Ser33/37/Thr41 and Ser45, which would mark it for proteasomal degradation, without affecting CK1 and GSK-3β enzyme activities. SKL2001 disrupted the Axin/β-catenin interaction, which is a critical step for CK1- and GSK-3β-mediated phosphorylation of β-catenin at Ser33/37/Thr41 and Ser45. The treatment of mesenchymal stem cells with SKL2001 promoted osteoblastogenesis and suppressed adipocyte differentiation, both of which were accompanied by the activation of Wnt/β-catenin pathway. SKL2001 did not affect either NF-κB or p53 reporter activity and inhibits β-catenin phosphorylation without affecting GSK-3β activity. Cell Research(from reference) Cell lines:HEK293 reporter and control cell lines Concentrations:20 μM Incubation Time:15 h |
Taxonomy Tree
| Kingdom | Organic compounds |
|---|---|
| Superclass | Organic acids and derivatives |
| Class | Carboxylic acids and derivatives |
| Subclass | Carboxylic acid derivatives |
| Intermediate Tree Nodes | Carboxylic acid amides |
| Direct Parent | 2-heteroaryl carboxamides |
| Alternative Parents | N-substituted imidazoles Isoxazoles Heteroaromatic compounds Furans Secondary carboxylic acid amides Oxacyclic compounds Azacyclic compounds Organooxygen compounds Organonitrogen compounds Organic oxides Hydrocarbon derivatives |
| Molecular Framework | Aromatic heteromonocyclic compounds |
| Substituents | 2-heteroaryl carboxamide - N-substituted imidazole - Azole - Furan - Imidazole - Isoxazole - Heteroaromatic compound - Secondary carboxylic acid amide - Oxacycle - Azacycle - Organoheterocyclic compound - Organonitrogen compound - Hydrocarbon derivative - Organic oxide - Organooxygen compound - Organic nitrogen compound - Organic oxygen compound - Aromatic heteromonocyclic compound |
| Description | This compound belongs to the class of organic compounds known as 2-heteroaryl carboxamides. These are compounds containing a heteroaromatic ring that carries a carboxamide group. |
| External Descriptors | Not available |
|
|
|
| ALogP | 0.929 |
|---|---|
| HBD Count | 1 |
| Rotatable Bond | 6 |
| Pubchem Sid | 504768000 |
|---|---|
| Pubchem Sid Url | https://pubchem.ncbi.nlm.nih.gov/substance/504768000 |
| IUPAC Name | 5-(furan-2-yl)-N-(3-imidazol-1-ylpropyl)-1,2-oxazole-3-carboxamide |
| INCHI | InChI=1S/C14H14N4O3/c19-14(16-4-2-6-18-7-5-15-10-18)11-9-13(21-17-11)12-3-1-8-20-12/h1,3,5,7-10H,2,4,6H2,(H,16,19) |
| InChIKey | PQXINDBPUDNMPE-UHFFFAOYSA-N |
| Smiles | C1=COC(=C1)C2=CC(=NO2)C(=O)NCCCN3C=CN=C3 |
| Isomeric SMILES | C1=COC(=C1)C2=CC(=NO2)C(=O)NCCCN3C=CN=C3 |
| PubChem CID | 16003447 |
| Molecular Weight | 286.29 |
Find and download the COA for your product by matching the lot number on the packaging.
| Lot Number | Certificate Type | Date | Item |
|---|---|---|---|
| Certificate of Analysis | Jun 09, 2025 | S413970 |
| Solubility | Solubility (25°C) In vitro DMSO: 57 mg/mL (199.09 mM); Ethanol: 57 mg/mL (199.09 mM); Water: Insoluble; |
|---|---|
| DMSO(mg / mL) Max Solubility | 57 |
| DMSO(mM) Max Solubility | 199.0988159 |
| Water(mg / mL) Max Solubility | <1 |
| Molecular Weight | 286.290 g/mol |
| XLogP3 | 0.800 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 6 |
| Exact Mass | 286.107 Da |
| Monoisotopic Mass | 286.107 Da |
| Topological Polar Surface Area | 86.100 Ų |
| Heavy Atom Count | 21 |
| Formal Charge | 0 |
| Complexity | 355.000 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| The total count of all stereochemical bonds | 0 |
| Covalently-Bonded Unit Count | 1 |